Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rifaat Safadi

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Medicina (Kaunas, Lithuania)|May 27, 2023
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced LipolysisEmad Maraga, Rifaat Safadi, Johnny Amer, et al.
International Journal of Obesity (2005)|February 15, 2026
The anti-obesity effect of namodenoson, an A3 adenosine receptor agonistPnina Fishman, Inbal Itzhak, Rifaat Safadi, et al.
The Israel Medical Association Journal : IMAJ|October 11, 2019
Ethnic Variations in Inflammatory Bowel Diseases Among Israel's PopulationsMahmud Mahamid, Ariella Bar-Gil Shitrit, Hana Amara, et al.
Drug Safety|June 1, 2024
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 StudiesAdi Mor, Scott Friedman, Sharon Hashmueli, et al.
The Pediatric Infectious Disease Journal|May 10, 2018
Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient PatientDiana Averbuch, Rifaat Safadi, Daniel Dar, et al.
Immunobiology|November 16, 2010
Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liverAmjad Horani, David Shoseyov, Sarit Doron, et al.
Therapeutic Advances in Respiratory Disease|July 6, 2012
Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effectsAmjad Horani, David Shoseyov, Isaac Ginsburg, et al.
International Journal of Molecular Medicine|October 23, 2019
The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in micePnina Fishman, Shira Cohen, Inbal Itzhak, et al.
Nutrients|September 27, 2025
Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Suha Shabaneh, Elliot M Berry, Ashraf Imam, et al.
Psychology, Health & Medicine|December 27, 2017
Pre-liver transplant psychosocial evaluation predicts post-transplantation outcomesAriel A Benson, Mina Rowe, Ahmad Eid, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Medicina (Kaunas, Lithuania)|May 27, 2023
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced LipolysisEmad Maraga, Rifaat Safadi, Johnny Amer, et al.
International Journal of Obesity (2005)|February 15, 2026
The anti-obesity effect of namodenoson, an A3 adenosine receptor agonistPnina Fishman, Inbal Itzhak, Rifaat Safadi, et al.
The Israel Medical Association Journal : IMAJ|October 11, 2019
Ethnic Variations in Inflammatory Bowel Diseases Among Israel's PopulationsMahmud Mahamid, Ariella Bar-Gil Shitrit, Hana Amara, et al.
Drug Safety|June 1, 2024
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 StudiesAdi Mor, Scott Friedman, Sharon Hashmueli, et al.
The Pediatric Infectious Disease Journal|May 10, 2018
Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient PatientDiana Averbuch, Rifaat Safadi, Daniel Dar, et al.
Immunobiology|November 16, 2010
Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liverAmjad Horani, David Shoseyov, Sarit Doron, et al.
Therapeutic Advances in Respiratory Disease|July 6, 2012
Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effectsAmjad Horani, David Shoseyov, Isaac Ginsburg, et al.
International Journal of Molecular Medicine|October 23, 2019
The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in micePnina Fishman, Shira Cohen, Inbal Itzhak, et al.
Nutrients|September 27, 2025
Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Suha Shabaneh, Elliot M Berry, Ashraf Imam, et al.
Psychology, Health & Medicine|December 27, 2017
Pre-liver transplant psychosocial evaluation predicts post-transplantation outcomesAriel A Benson, Mina Rowe, Ahmad Eid, et al.
Pageof 12